Design Three arm, open label, pragmatic, multicentre, randomised, phase 3 superiority trial (BASIL-3). Setting 35 UK NHS vascular units. Participants Patients with chronic limb threatening ischaemia ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond's ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

Low grade non-muscle invasive bladder cancer (Ta) confirmed by cystoscopy and cold cup biopsy of the visualized tumor at screening or within 8 weeks before screening Negative voiding cytology for high ...

CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD - - Flexible Dosing and Extended Duration would be Important Differentiators from Existing Approved Therapies and Other ...

(6) Ideally, an integrated PTB prediction platform would analyze all nine biomarkers; here, these three were selected to cover a range of sizes and analyte complexities. For experiments involving ...

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

The federal government says it's moving ahead with a plan to label so-called forever chemicals as toxic and expects to begin ...